about
Cardiac cachexia: hic et nuncPharmacokinetics of drugs in cachectic patients: a systematic reviewUric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey.Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey.General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011.Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in womenCachexia: common, deadly, with an urgent need for precise definition and new therapies.How does cachexia influence survival in cancer, heart failure and other chronic diseases?Cachexia as a major public health problem: frequent, costly, and deadly.Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary diseaseExercise-induced changes in iron status and hepcidin response in female runners.Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)Emerging biomarkers in heart failure and cardiac cachexiaTitration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexiaImpact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke--a retrospective analysis.The obesity paradox in chronic disease: facts and numbers.Infective endocarditis due to Abiotrophia defectiva: a report of two cases.Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure.The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.Cardiovascular Function in Intensive Care Medicine or Homo Mensura EstRight ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.Biomarkers for chronic heart failure.Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study.Atrial natriuretic peptide and related peptides.Anticoagulants, antiplatelets, and statins in heart failure.Atrial fibrillation in chronic non-cardiac disease: where do we stand?Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.Cardiac cachexia: a systematic overview.Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.Overview of emerging pharmacotherapy in chronic heart failure.Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling
P50
Q26744140-8E03A45F-D62C-4EE9-9419-86F286356068Q28535322-F6F94466-87A6-49D3-A842-06832692DE7CQ30990590-6D95FAEC-F801-4149-A433-894140947AB3Q31064781-6EAC031D-7FF3-4E41-8B3C-AD10CE095D3DQ31106553-09E30484-898F-4D78-8A57-84464466AAAFQ33385180-81D96E98-5405-4CFA-8AA9-FE60DDC2BB98Q33701324-D2E98163-C4AF-4A35-98E4-058E246720CCQ33926447-24027B79-DE63-4CC4-A60B-0BD3648874DDQ34012016-BB4A1FC1-D47B-4BC2-AC66-DD6EDA3FBDFAQ34013227-33434E22-8565-4E0C-B876-59A2FCBD5247Q34335859-0083477D-9E90-4B76-A5E5-5C26415F8B5BQ34390635-B4526EC2-01CA-4A46-9843-32D0C6F55767Q34466749-1B6D0DFD-188C-4F89-9C68-BDE6EDA71C98Q34614664-1C73033B-1129-4542-A881-36094D1D1F3AQ34697156-16FAE417-D00F-4039-A077-487E4B962ED5Q34836097-A2F0643E-347C-41E3-9D60-462F6F5935FCQ35006600-18210F9B-F62B-4255-BC56-D4A4BC0BEF45Q35053626-C5ED1D74-95D2-4431-9F6F-472B31C08E79Q35569439-B3A01477-028D-479A-8D08-8DF8DB7ADC82Q35767140-D609D980-C920-48E4-8FFB-71CD61A262A9Q35828089-4FD7A694-ECC6-4924-8AA4-A0748E6C994FQ36034333-7FDCB769-F52A-4342-ABE1-1DDACD3BB57FQ36084695-AF0A3798-8977-4588-87F4-A379C5F726E9Q36453374-6DDF2715-AA7F-498A-A798-59BB75C6DE16Q36499172-8C2C8FBA-B232-4BCE-899F-5223E3C96F43Q36805932-C6B5C04D-E6A1-42CD-B425-97388798613EQ36806466-292330CD-FD30-483E-84C1-15489E6BFCB3Q36814807-B3714FCB-233A-4246-A16E-2C76930B18D3Q36829069-66DABEE8-3340-4DA6-AADA-A2F69EB12F74Q36896608-80101544-05F9-41BB-9028-18CF5B6C7642Q37099316-833B74A2-3854-42F3-8329-F15CABD1E737Q37122459-968BBFE2-D4DE-49B1-A6EA-FCDAE2C77DC1Q37320333-407C5D00-92AD-47FC-89EE-E1D2745B5CA0Q37343128-39CF0592-0DD8-4A42-B3ED-A1CCDE3BE8FAQ37368578-86C3961C-65D1-4F99-B278-EFD5A043704BQ37445574-B4088683-7699-44D6-8AF9-C0480E7579F1Q37534382-782D54E7-CA36-44F7-9DC8-57C252694D00Q37552943-AB2B3FB8-9206-4A77-8F34-5AA9EEB3B2D5Q37561789-5C6B615B-8AD5-4F2E-88C4-3E1EDE4E4736Q37580740-12F146E4-4058-4C9E-A276-030AA3971046
P50
name
Mitja Lainscak
@en
Mitja Lainscak
@nl
type
label
Mitja Lainscak
@en
Mitja Lainscak
@nl
prefLabel
Mitja Lainscak
@en
Mitja Lainscak
@nl